ArticleJournal of attention disorders2025
A Customized Medication Adherence Enhancement Program for Adolescents and Young Adults With ADHD (CAE-ADHD): Primary Outcomes.
Article in Journal of attention disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundADHD is a generally persistent neurodevelopmental condition that can have significant consequences if left untreated, and medication, often in conjunction with psychotherapy, is the first-line treatment with well-established efficacy. Adolescents and young adults (AYAs) represent a particularly vulnerable and understudied subgroup and there remains a significant concern regarding transition to treatment independence, treatment engagement and medication adherence in this population. We report the results from a pilot trial evaluating Customized Adherence Enhancement-ADHD (CAE-ADHD), a psychosocial intervention for AYAs with ADHD, aimed to increase independence in managing ADHD and improve ADHD symptoms.
methodsWe used an iterative process to modify an existing psychosocial intervention to address engagement, independence, and adherence in AYAs with ADHD, originally developed for AYAs with bipolar disorder. To develop the CAE-ADHD intervention, we conducted focus groups and cognitive interviews with AYA with ADHD. We then conducted a pilot feasibility and efficacy study in AYAs with ADHD (
resultsThe sample consisted of 12 participants ages 16 to 24 years with a diagnosis of ADHD, obtained via self-report, and currently prescribed stimulant medication. Mean age of the sample was 19.5 years, 58.33% female, 25% non-White. Participation and retention were strong with 93.33% of sessions completed overall and 10/12 participants completing all sessions. AYAs showed a trend toward improvement in ADHD symptoms as measured by the ADHD RS-5, statistically significant improvement in transition readiness and ADHD knowledge. There was no significant change in adherence.
conclusionsThis first of its kind feasibility and efficacy pilot study for a novel intervention, CAE-ADHD, found high engagement and improvement in ADHD symptoms, transition readiness, and ADHD knowledge from baseline to week 12.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.